The Pfizer/BioNTech Covid-19 vaccine is effective against the coronavirus variant that emerged from South Africa, according to a new study.
In a US study of 20 vaccine recipients, researchers at the University of Texas Medical Branch at Galveston found that the vaccine neutralises the virus with the N501Y and E484K mutation.
Researchers at New York University, investigating the South African variant in a study of 10 people, also reportedly found the immune antibodies made by the vaccine were still able to destroy the virus.
But the researchers found the body didn't make as many of the immune antibodies, according to the Daily Mail. The New York University researchers, led by microbiologist Dr Nathaniel Landau, said: "The findings suggest